Replacing Tort Liability with Private Insurance
Some academic economists favor the approach
of eliminating tort liability, except perhaps
for injuries between "strangers"
(such as injuries from automobile accidents).(1)
Potential victims would rely to a greater
extent on their own insurance for protection
against injury risks. In cases in which
potential injurers could cost-effectively
reduce those risks, they would be motivated
to do so to the extent that they could gain
a marketing advantage--by advertising the
safety of their products or by offering
injury compensation in a warranty, purchase
contract, or the like.(2) Some increases
in government regulation might also occur.
From the standpoint of efficiency, eliminating
tort liability would have several desirable
implications, although it would fall short
of the ideal. It would give potential victims
the incentive to take all cost-effective
precautions and to obtain the optimal amount
of risk spreading through insurance or other
compensation contracts. And provided that
the insurance and contract terms were clear
enough, the amount of litigation would decline
significantly, reducing both transaction
costs and the inefficiencies associated
with erroneous judgments. However, this
approach would weaken incentives for potential
injurers to exercise cost-effective forms
of care (at least those not required by
regulation) and could increase inefficiencies
associated with imprecise or too-stringent
regulation.
From the standpoint of equity, the implications
of shifting primary responsibility for injury
costs to victims could be considered both
good and bad. Lower liability-related costs
for businesses should lead to lower prices
for many consumer goods and services and
reduce the extent to which consumers are
implicitly forced to pay for unwanted insurance
for nonpecuniary damages. But victims would
usually get compensation only for pecuniary
losses, and those who had not bought insurance
might get no compensation at all. Moreover,
injurers would pay compensation only to
the extent that they had contracted in advance
to do so, and in cases of subtle, delayed,
or indirect harm, some injurers' roles might
go undetected because few, if any, plaintiffs'
attorneys would be working to identify the
causes of injuries.
A narrower variant of the same basic idea
would eliminate liability only for those
products (or features of products) that
have been certified as safe by a federal
body, such as the Food and Drug Administration,
the National Highway Traffic Safety Administration,
or the Consumer Product Safety Commission.
Many of the arguments for and against completely
eliminating tort liability would apply here
as well, at least qualitatively. For example,
the same efficiency and equity implications
would follow from making consumers bear
the risk of using the relevant products.
The main immediate difference from the standpoint
of efficiency is that focusing on products
that satisfied federal safety regulations
would presumably limit the extent of any
increase in injury risks. From the perspective
of equity, removing the threat of liability
from firms whose products met federal standards
might be particularly appropriate. Over
time, however, this variant could result
in a greatly expanded role for federal regulators--with
potentially significant consequences for
both efficiency and equity--as firms and
industries seeking to exempt their products
from liability pushed to broaden the scope
of federal safety standards.
Replacing Tort Liability with Public Insurance
Another variant of the previous approach
would eliminate (or greatly restrict) tort
liability as described above but replace
it with a public insurance system, like
the present workers' compensation system
or the fund for vaccine victims. In this
option, victims would receive compensation
from a government fund according to a fixed
schedule based on the type of injury they
had and other relevant factors.(3) To finance
the fund, businesses would pay "experience-rated"
premiums that reflected the previous record
of injuries associated with their products.
(Companies would ultimately pass on the
costs of those premiums to their customers,
workers, or investors in the form of higher
prices, reduced wages, or lower returns
on capital, respectively.) Depending on
the details of the proposal, nonprofit organizations
and state and local governments might also
participate. But cost considerations would
probably make it impractical to rate and
collect premiums from individuals, so the
injuries they caused might still be handled
through the tort system.
Proponents of this variant hope that by
standardizing the amount of compensation
awarded for similar injuries, this approach
would cap or reduce punitive damages and
compensatory awards for pain, suffering,
and other nonmonetary losses. The effects
of reducing such nonpecuniary awards would
be qualitatively similar to (though not
as large as) the effects of simply eliminating
tort liability. Again, potential victims
would have better incentives to take efficient
precautions, and risk would be distributed
more efficiently (because consumers would
not be implicitly paying for so much unwanted
insurance for nonpecuniary damages). However,
some injurers might not face sufficient
penalties, and some victims might not receive
full compensation for their pain and suffering.
Other implications of the public insurance
approach flow from its shift away from litigation
to an administrative mechanism. For example,
one key argument made for the approach is
that it would significantly reduce transaction
costs from the 54 percent estimated under
the current tort system. (However, transaction
costs would probably remain higher than
the 20 percent estimated for state workers'
compensation programs because of higher
costs for such things as determining which
injuries were compensable and associating
injuries with particular injurers.) Conversely,
one argument against public insurance is
that the schedule of damages might not do
justice to individual cases. Another is
that in some cases of subtle, indirect,
or delayed harm--such as cancers with long
latencies caused by exposure to a particular
chemical-- victims might not recognize that
they had suffered a compensable injury,
since there would be few, if any, plaintiffs'
attorneys working to identify injury causes.
In addition, this option would represent
a sharp departure from current practice
for injuries that are judged under a negligence
standard. Providers of medical care, for
example, are now held liable only for injuries
considered to result from negligence; but
with this option, all compensable injuries
to patients under their care would be reflected
in their assessed premiums for the public
fund.
The incentives for potential injurers to
exercise care might be more or less efficient
under a public insurance program than they
are now. For a firm to be encouraged to
take all cost-effective precautions, its
assessed premiums would need to reflect
all of the effects of its actions on expected
future injury costs, and the experience
rating would probably not be that thorough.
However, even if the new incentives fell
on the low side, the error could be smaller
than it is now if current incentives are
inefficiently high because of mistaken or
excessive trial awards.
Lawsuits Consumer Fraud
(St. Paul, Minn.: West Group, 1999), p. 926.
More...
Lawsuits Consumer Fraud
26, no. 2 (June 1997). 18. George L.
More...
New York Lawyers Information
Instead of pursuing only a selected subset of the alleged injurers (often just the single party with the deepest pockets) and shifting the costs of dealing with the remaining parties to that selected group, plaintiffs must sue everyone from whom they hope to collect damages.
More...
Lawsuits Consumer Fraud Class Actions Securities Lawyers - Complaint Center
This basically means that the victim is being accused of knowingly exposing themselves to the harm that ultimately injured them. Although one cannot consent to everything, e.g., murder, consent (if proven) can help the defendant defeat the victim's case. Finally, victims may be accused of contributing to their own injuries.
More...
Product Recall Safety Legal and Lawyer Attorney Resources
Consumer Product Safety Information: official website, including recalls, reports, lawyers, attorneys, class action, lawsuits, settlements and alerts such ... www.productrecallsafetyalerts.com/ - 20k -
More...
Product Recall Safety Legal and Lawyer Attorney Resources
Consumer Product Safety Information: official website, including recalls, reports, lawyers, attorneys, class action, lawsuits, settlements and alerts such ... www.productrecallsafetyalerts.com/ - 20k -
More...
Class Action Lawsuits Consumer Fraud Class Actions Securities Lawyers - Complaint Center
T.S. 320 (Oct. 21, 1994), and thus defines the scope of the United States' obligations under the treaty. See Relevance of Senate Ratification History to Treaty Interpretation, 11 Op. O.L.C. 28, 32-33 (1987).
More...
Class Action Lawsuit Lawyers and Attorneys - Pfizer maker of Celebrex
The Kahn Gauthier Law Group and Class Action Lawsuit Lawyers and Attorneys are investigating possible legal actions after medical studies raised concerns ... www.classactionamerica.com/affiliates/ gm/classactionlawsuit.asp?lngCaseID=1210 - 62k -
More...
Class Action Lawsuit Lawyers and Attorneys - Pfizer maker of Celebrex
The Kahn Gauthier Law Group and Class Action Lawsuit Lawyers and Attorneys are investigating possible legal actions after medical studies raised concerns ... www.classactionamerica.com/affiliates/ gm/classactionlawsuit.asp?lngCaseID=1210 - 62k -
More...
[1]